http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3302438-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2aa388e460f6cf478bd46c925c6ab10e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29L2031-753
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-074
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C43-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-203
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
filingDate 2015-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd15102ca231d9ce239a5d950b69891e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc47ad6547dfa43de13ce60305877316
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0fe60be089fa08ce079bb45b0311e68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eef97d798193e989eb5b5d60dd2b595
publicationDate 2019-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3302438-A4
titleOfInvention ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
priorityDate 2015-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03037385-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016189481-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282379

Total number of triples: 27.